Slaughter and May and Davis Polk & Wardwell have been instructed by Shire to advise the UK pharmaceutical giant on a £27bn unsolicited takeover bid from US drugmaker AbbVie.

AbbVie, whose offer was formally announced today (20 June), has until 18 July to make a formal bid, according to Takeover Panel rules.